Delivery Order SPE2DB20D2014-SPE2DB24FB24G
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $28,639.87 from the Defense Logistics Agency (DLA). The contract is for the provision of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a performance period through November 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a specialty pharmaceutical product, with a period of performance through March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $23,490.57 firm-fixed-price contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of June 26, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order worth $47,077.25 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is a firm fixed-price delivery order for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen Drug Corp is the prime contractor and the contract does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,536.04 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a specialty medication. The award has an ultimate completion date of August 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price valued at $31,354.89 and has an ultimate completion date of May 28, 2025. The contract is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,002.82 firm fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product used to treat various medical conditions. The award has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a $13,322.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, was issued by the Defense Logistics Agency (DLA) and covers the delivery of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,884.59 firm fixed price delivery order is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. This award does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB24GDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order with a potential value of $18,046.26. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of March 6, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 3/5/24 |